Attention Deficit Hyperactivity Disorder (ADHD) is a debilitating condition that affects over 366 million adults worldwide, yet there are limited treatment options beyond medication and therapy. That is until Neurode, a Sydney-based startup, developed a revolutionary wearable headband that tracks and treats ADHD symptoms. The device, which takes just 20 minutes a day to use, uses light electrical stimulation in the prefrontal cortex to balance the brain and alleviate symptoms such as lack of focus.
Co-founder Nathalie Gouailhardou, a neuroscientist who has lived with ADHD since childhood, was dissatisfied with traditional medication due to its side effects. She worked with friend and co-founder Damian Sofrevski to develop the headband, which was born out of an idea to take non-invasive brain imaging technology out of the lab and turn it into a treatment device. The duo reduced the size and cost of the device by 100 times, making it an accessible option for those suffering from ADHD.
Neurode has filed patents for its device and has raised $3.5 million in pre-seed funding to support its clinical trials. The wearable is currently available through a private beta, with a goal of obtaining FDA approval in the future. Alex Morgan, partner at Khosla Ventures, praised the company’s innovative approach, citing the need for a treatment that is not only effective but also accessible.
Neurode’s device has the potential to expand beyond ADHD treatment, potentially addressing conditions such as age-related cognitive decline and depression. Co-founder Gouailhardou believes that the device can empower individuals with ADHD to take control of their treatment and see meaningful results. With its innovative technology and commitment to making a difference, Neurode is poised to revolutionize the way we treat ADHD and potentially other neurological conditions.
